Levetiracetam Ametas (Levetiracetam)

Levetiracetam exerts its anticonvulsant effect by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal membranes and reduces the release of excitatory neurotransmitters such as glutamate, thereby lowering neuronal hyperexcitability that can trigger seizure activity.

The dosage of levetiracetam is individualized and set by the prescribing clinician based on the patient’s age, weight, renal function, seizure type, and response to therapy. The prescriber may start with a low dose and titrate upward as needed, following established clinical guidelines.

Levetiracetam is classified as Pregnancy Category B, indicating that animal studies have not shown risk, but adequate human data are lacking. It may be used during pregnancy only when the potential benefit justifies the potential risk. Limited data suggest it is excreted in breast milk; breastfeeding decisions should be made in consultation with a healthcare provider.

To place an order, visit the product page on gnhindia.com and submit an enquiry specifying the required quantity of Levetiracetam Ametas. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with older antiepileptics such as carbamazepine or phenytoin, levetiracetam has a relatively favorable side‑effect profile, minimal protein binding, and limited hepatic metabolism, reducing the likelihood of drug‑drug interactions. However, individual response varies, and choice of therapy should be guided by seizure type, comorbidities, and physician judgment.

The product should be stored at ambient temperature below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. No special refrigeration is required for this oral formulation.

Levetiracetam Ametas is taken orally, usually with or without food, as directed by the prescribing clinician. Tablets or capsules are swallowed whole with a glass of water. The exact dosing schedule, including frequency and timing, is determined by the healthcare provider based on the patient’s therapeutic needs.

Although uncommon, serious adverse events can include severe skin reactions such as Stevens‑Johnson syndrome, significant mood alterations including depression or suicidal ideation, hematologic abnormalities, and rare cases of multi‑organ hypersensitivity. Patients should be instructed to seek immediate medical attention if they experience rash, mood changes, or other concerning symptoms.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised in patients with severe renal impairment, as dose adjustment is required, and in those with a history of psychiatric disorders, who should be closely monitored. Pregnant or breastfeeding women should use it only when clearly indicated.